Allergy Therapeutics results nothing to sneeze at
AIM-listed speciality pharmaceuticals company Allergy Therapeutics has reported a 10.6% increase in revenues for the six months ended 31st December.
AIM-listed speciality pharmaceuticals company Allergy Therapeutics has reported a 10.6% increase in revenues for the six months ended 31st December.
International packaging firm DS Smith has announced the disposal of its plastics business to Olympus Partners for an enterprise value of $585 million.
Shares in defence contractor Ultra Electronics shot 11.45% higher despite a 29.7% drop off in pre-tax profits for the year ended 31st December.
Inside the mind of the Master Investor: British billionaire investor Jim Mellon reveals his latest thoughts on the markets.
Robert Stephens, CFA, considers the turnaround potential of two underperforming FTSE 100 shares – defence giant BAE Systems and broadcaster ITV.
The share price of FTSE 250 brick and concrete manufacturer Ibstock rose by 4.14% after the firm posted a 19.1% improvement in pre-tax profits for 2018.
Drug discovery firm e-Therapeutics has seen its share price drop by 4.26% as it continued to make a loss during the year ended 31st January.
AIM-listed customer engagement specialist Netcall has said that pre-tax profits for the half year ended 31st December were up by 49%.
Gold and silver have been rising on the back of a weaker US dollar. Ex-IG chief market strategist David Jones looks at whether the rally will continue.
Mark Watson-Mitchell has his eye on Springfield Properties, Scotland’s only quoted housebuilder, which recently put out some very strong numbers.